Webb30 dec. 2024 · Clariscan 0.5 mmol/mL is a sterile, clear, colorless to yellow, aqueous solution for intravenous injection containing 376.9 mg/mL gadoterate meglumine and … WebbDotarem® (Gadoteric acid - Gadoterate meglumine) Dotarem. (Gadoteric acid - Gadoterate meglumine) Launched in 1989 in France, Dotarem ® is currently available …

检索结果-暨南大学图书馆

WebbClariscan (Gadoterate Meglumine) injection for intravenous use is a macrocyclic, ionic gadolinium-based contrast agent (GBCA) Indicated for intravenous use with magnetic resonance imaging (MRI) in brain (intracranial), spine, and associated tissues in adult and pediatric patients WebbMRI contrast agents may be administered by injection into the blood stream or orally, ... In 2024 GE Healthcare launched a macrocyclic extracellular gadolinium based contrast agent containing gadoteric acid as gadoterate meglumine under … cb750four マフラー

(PDF) Use of gadolinium contrast agents in paediatric population ...

It is used for imaging of blood vessels and inflamed or diseased tissue where the blood vessels become 'leaky'. It is often used when viewing intracranial lesions with abnormal vascularity or abnormalities in the blood–brain barrier. Gadoteric acid is used for MRI imaging of the brain, spine, and associated tissues for adult and pediatric (2 years of age or older) patients. The meglumine salt it takes the form of crosses the blood brain barrier of tissue with abnormal vascu… http://www.uspbpep.com/usp29/v29240/usp29nf24s0_m34600.html Webb10 maj 2024 · Effective with date of service Jan. 1, 2024, the Medicaid and NC Health Choice programs cover gadoterate meglumine injection, for intravenous use (Clariscan) for use in the Physician’s Administered Drug Program (PADP) when billed with HCPCS code A9575 - Injection, gadoterate meglumine, 0.1 mL. cb750four k0 メーター